Search

Your search keyword '"Gertz, Shira"' showing total 306 results

Search Constraints

Start Over You searched for: Author "Gertz, Shira" Remove constraint Author: "Gertz, Shira"
306 results on '"Gertz, Shira"'

Search Results

1. Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.

2. Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.

3. Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network.

4. Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.

5. NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

6. Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C.

7. Immunocompromised-Associated Pediatric Acute Respiratory Distress Syndrome: Experience From the 2016/2017 Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Prospective Cohort Study*

8. Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.

9. Prevalence of Bacterial Codetection and Outcomes for Infants Intubated for Respiratory Infections

10. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.

11. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.

12. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

13. Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network

14. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.

15. Noninvasive Ventilation for Pediatric Acute Respiratory Distress Syndrome: Experience From the 2016/2017 Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Prospective Cohort Study*

17. The Modified Clinical Progression Scale for Pediatric Patients: Evaluation as a Severity Metric and Outcome Measure in Severe Acute Viral Respiratory Illness

18. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management.

19. Association of Asthma With Treatments and Outcomes in Children With Critical Influenza

20. Paediatric critical COVID-19 and mortality in a multinational prospective cohort

21. Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents

22. Maternal Vaccination and Risk of Hospitalization for Covid-19 Among Infants

24. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management

25. Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation

26. Candidacy for Extracorporeal Life Support in Children After Hematopoietic Cell Transplantation: A Position Paper From the Pediatric Acute Lung Injury and Sepsis Investigators Network’s Hematopoietic Cell Transplant and Cancer Immunotherapy Subgroup

31. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study

32. Epidemiology of Lower Extremity Deep Venous Thrombosis in Critically Ill Adolescents

34. Physical Rehabilitation in Critically Ill Children: A Multicenter Point Prevalence Study in the United States

35. Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection

36. Association of Asthma With Treatments and Outcomes in Children With Critical Influenza

37. Clinical Course Associated with Aseptic Meningitis Induced by Intravenous Immunoglobulin for the Treatment of Multisystem Inflammatory Syndrome in Children

41. Challenges and opportunities for pediatric severe TBI—review of the evidence and exploring a way forward

42. Performance of the PEdiatric Logistic Organ Dysfunction-2 score in critically ill children requiring plasma transfusions

43. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months--17 States, July 2021-January 2022

44. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years--United States, July-December 2021

45. Factors Associated With COVID-19 Non-vaccination in Adolescents Hospitalized Without COVID-19

46. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years--United States, June-September 2021

47. Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment Response

48. Hyperchloremia Is Associated With Complicated Course and Mortality in Pediatric Patients With Septic Shock*

50. Paediatric critical COVID-19 and mortality in a multinational prospective cohort

Catalog

Books, media, physical & digital resources